Imbruvica (ibrutinib)

pCPA File Number: 22541

Negotiation Status:

Under consideration for negotiation

Indication(s):

Waldenström's Macroglobulinemia

Sponsor/Manufacturer:

Janssen Inc.

CDA-AMC Project Number:

PC0328-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable